A look at how the coronavirus has changed our health care delivery landscape; rebates don’t increase premiums in Medicare Part D; meanwhile, prescription drug prices continue to drive up overall spending; and, a new study puts a price tag on what modifiable health behaviors cost us.
Lawmakers reignite negotiations on the next coronavirus stimulus package; drugmakers bend patent rules to protect their pricing power; an in-depth look at what’s driving health care spending; and, how technology is helping better address population health.
A new report exposes hospitals’ cost-shifting; a recent study details the negative impact of restricting rebates in Part D; meanwhile, drug prices are found to be rising faster than other health care services; and, emergency transportation continues to drive up health care costs.
Hospital testing charges prompt questions; surprise medical billing drives up premiums; telehealth continues to reshape care delivery; and, drug and device manufacturers paid hundreds of millions to teaching hospitals.
Patients continue to find themselves vulnerable to exorbitant coronavirus testing hospital fees; voters are unsupportive of the rebate rule; plans to improve rural health focus on broadband and telehealth; and, the transition to Medicaid managed care plans improves primary care for states.
Experts warn policymakers not to be distracted by Big Pharma’s ‘blame game’; bigger health systems don’t lead to better health care; behavioral health patients account for a disproportionate share of health spending; and, what we’re learning from virtual house calls.
A recent study shows Medicare Part D encouraging the use of generic drugs; Medicaid enrollment going up, but not just because of the newly uninsured; a new alternative payment model is introduced for rural health; and, experts look at what the coronavirus has taught us.
The White House issues coronavirus Executive Orders; a recent study takes a look at hospital charges during the pandemic; the rise of the surgical assistant presents another front in the battle against surprise medical bills; and, interoperability has become a priority for payers.
Lawmakers continue to focus on advancing the next coronavirus legislative package; a new report identifies private equity interests as the leading cause of surprise medical bills; how the rebate rule will only increase costs for seniors and taxpayers; and, telehealth utilization explodes among the Medicare population.
A new survey finds the majority of Americans fear rising drug costs due to COVID-19; meanwhile, a separate new poll underscores the important role that PBMs play in helping better manage costs; data points to crucial missed opportunities in regards to Medicaid expansion; and, the continued corporatization of hospitals causes increasing alarm.